CRXM
Gene Biotherapeutics Inc

37
Loading...
Loading...
Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company. The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease, and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers. The company was founded by Christopher J. Reinhard and Tyler M. Dylan-Hyde in December 2003 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Taxus Cardium Pharmaceuticals Group Inc?
What is the 52-week high for Taxus Cardium Pharmaceuticals Group Inc?
What is the 52-week low for Taxus Cardium Pharmaceuticals Group Inc?
What is the 50-day moving average of Taxus Cardium Pharmaceuticals Group Inc?

Latest CRXM News

View
No CRXM news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.